1. Home
  2. EXK vs MIRM Comparison

EXK vs MIRM Comparison

Compare EXK & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Endeavour Silver Corporation (Canada)

EXK

Endeavour Silver Corporation (Canada)

HOLD

Current Price

$12.14

Market Cap

3.5B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$89.55

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXK
MIRM
Founded
1981
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.2B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
EXK
MIRM
Price
$12.14
$89.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$13.94
$108.92
AVG Volume (30 Days)
11.4M
613.8K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.59
EPS
N/A
N/A
Revenue
N/A
$19,138,000.00
Revenue This Year
$74.46
$24.90
Revenue Next Year
$12.39
$19.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.95
$36.88
52 Week High
$15.15
$109.28

Technical Indicators

Market Signals
Indicator
EXK
MIRM
Relative Strength Index (RSI) 48.99 36.78
Support Level $10.50 $72.17
Resistance Level $12.75 $107.51
Average True Range (ATR) 0.85 3.76
MACD 0.02 -2.43
Stochastic Oscillator 45.49 12.71

Price Performance

Historical Comparison
EXK
MIRM

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: